This is a Validated Antibody Database (VAD) review about rat Gabrb3, based on 6 published articles (read how Labome selects the articles), using Gabrb3 antibody in all methods. It is aimed to help Labome visitors find the most suited Gabrb3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Abcam
mouse monoclonal (N87/25)
  • immunocytochemistry; mouse; 1:200; loading ...; fig ev1t-u
Abcam Gabrb3 antibody (Abcam, ab98968) was used in immunocytochemistry on mouse samples at 1:200 (fig ev1t-u). EMBO Rep (2020) ncbi
mouse monoclonal (N87/25)
  • immunocytochemistry; rat; 1:500; fig 5d
In order to investigate the mechanism by which oxytocin attenuates oxygen-glucose deprivation-reperfusion injury, Abcam Gabrb3 antibody (Abcam, ab98968) was used in immunocytochemistry on rat samples at 1:500 (fig 5d). Sci Rep (2016) ncbi
mouse monoclonal (N87/25)
  • western blot; rat; 1:1000; loading ...; fig 3c
Abcam Gabrb3 antibody (Abcam, ab98968) was used in western blot on rat samples at 1:1000 (fig 3c). J Mol Neurosci (2016) ncbi
mouse monoclonal (N87/25)
  • western blot; human; 1:5000
Abcam Gabrb3 antibody (Abcam, ab98968) was used in western blot on human samples at 1:5000. Transl Psychiatry (2013) ncbi
Santa Cruz Biotechnology
mouse monoclonal (D-12)
  • western blot; mouse; loading ...; fig 3c
Santa Cruz Biotechnology Gabrb3 antibody (Santa Cruz, sc-376252) was used in western blot on mouse samples (fig 3c). Theranostics (2020) ncbi
Synaptic Systems
guinea-pigs polyclonal
  • immunohistochemistry; rat; 1:500; fig 10
Synaptic Systems Gabrb3 antibody (Synaptic Systems, 224 404) was used in immunohistochemistry on rat samples at 1:500 (fig 10). elife (2016) ncbi
Articles Reviewed
  1. Bera S, Camblor Perujo S, Calleja Barca E, Negrete Hurtado A, Racho J, de Bruyckere E, et al. AP-2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons. EMBO Rep. 2020;21:e47954 pubmed publisher
  2. Zhang W, Zhou M, Lu W, Gong J, Gao F, Li Y, et al. CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics. 2020;10:3000-3021 pubmed publisher
  3. Kaneko Y, Pappas C, Tajiri N, Borlongan C. Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro. Sci Rep. 2016;6:35659 pubmed publisher
  4. Kerti Szigeti K, Nusser Z. Similar GABAA receptor subunit composition in somatic and axon initial segment synapses of hippocampal pyramidal cells. elife. 2016;5: pubmed publisher
  5. Pan B, Lian J, Huang X, Deng C. Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats. J Mol Neurosci. 2016;59:36-47 pubmed publisher
  6. Fatemi S, Folsom T, Rooney R, Thuras P. Expression of GABAA ?2-, ?1- and ?-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry. 2013;3:e303 pubmed publisher